AI assistant
Sending…
TherapeuticsMD, Inc. — Director's Dealing 2015
Feb 18, 2015
35134_dirs_2015-02-17_0ff9d022-3383-4551-b61a-c7434c336f85.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 5 — Annual Statement of Changes in Beneficial Ownership
Issuer: TherapeuticsMD, Inc. (TXMD)
CIK: 0000025743
Period of Report: 2014-12-31
Reporting Person: Milligan John C.K. IV (Director, President/Secretary)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2014-05-03 | Common Stock | G | 1500000 | $0.00 | Disposed | 2392187 | Indirect |
| 2014-05-03 | Common Stock | G | 1500000 | $0.00 | Acquired | 1500000 | Indirect |
| 2014-08-25 | Common Stock | G | 250000 | $0.00 | Disposed | 1492419 | Direct |
| 2014-08-25 | Common Stock | G | 250000 | $0.00 | Acquired | 2642187 | Indirect |
Footnotes
F1: By John C.K. Milligan Revocable Trust U/A 08/10/2009, as amended.
F2: By grantor-retained annuity trust.
More from TherapeuticsMD, Inc.
Interim / Quarterly Report
2026
May 12
Regulatory Filings
2026
May 12
Major Shareholding Notification
2026
Apr 7
Annual Report
2026
Apr 1
Regulatory Filings
2026
Apr 1
Regulatory Filings
2026
Mar 30
Annual Report
2026
Mar 30
Regulatory Filings
2026
Jan 20
Director's Dealing
2025
Dec 29
Regulatory Filings
2025
Dec 16